跳至主要内容
临床试验/NCT05088577
NCT05088577已完成不适用

Evaluation of the Effects of Egg Consumption and Its Enrichment With Annatto on Biomarkers of Cardiovascular Risk and Satiety in Adults.

Universidad de Antioquia1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2019年10月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
105
试验地点
1
主要终点
Total cholesterol

研究概览

简要总结

Healthy adult volunteers (n= 105; 18-59 years) were randomly allocated to consume daily for 8 weeks, either two whole eggs (egg group), two whole eggs added with annatto (annatto-enriched egg group), or two egg whites (control). Volunteers were asked to continue with the habitual physical activity and diet, except for the consumption of additional eggs, egg whites or annatto.

It is hypothesized that participants consuming eggs would have a less atherogenic lipid profile, feel more satisfied and increase antioxidant levels in blood, compared to the control group. Participants in the annatto-enriched egg group would have greater antioxidant capacity than the egg group and compared to control.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 59 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 18-59 years
  • Body Mass Index (BMI): 18,5 - 29,9 kg/m2
  • Healthy volunteers
  • Good disposition to consume either eggs, egg whites or eggs added with annatto
  • To have signed the informed consent

排除标准

  • Fasting blood triglycerides > 500mg/dL, Total Cholesterol > 240mg/dL, glucose > 126mg/dL or diabetes.
  • Blood pressure: >140/90 mmHg.
  • History or having any of the following: liver, kidney, or heart disease, cancer, endocrine or gastrointestinal disorders -especially those that limit food absorption.
  • Use of medications to lower blood lipids or glucose.
  • Consumption of multivitamins or nutraceuticals.
  • Plan to lose body weight, pregnancy or breastfeeding.
  • Any known allergy or intolerance to eggs or annatto.

结局指标

主要结局

Total cholesterol

时间窗: Change from Baseline Total cholesterol at 8 weeks

Fasting blood total cholesterol in mg/dL

Systolic Blood Pressure

时间窗: Change from Baseline Systolic Blood Pressure at 8 weeks

Systolic blood pressure in mmHg will be used to present the results of this variable, as follow: e.g. 130 mmHg

Triglycerides

时间窗: Change from Baseline Triglycerides at 8 weeks

Fasting blood triglycerides in mg/dL

Blood lutein levels

时间窗: Change from Baseline Blood lutein levels at 8 weeks

Fasting blood lutein levels in micrograms per mL

Blood bixin levels

时间窗: Change from Baseline Blood bixin levels at 8 weeks

Fasting blood bixin levels in %

Apolipoprotein B (ApoB)

时间窗: Change from Baseline ApoB at 8 weeks

Fasting blood ApoB in mg/L measured by Nuclear Magnetic Resonance

Very low-density lipoprotein (VLDL) cholesterol

时间窗: Change from Baseline VLDL cholesterol at 8 weeks

Fasting blood VLDL cholesterol in mg/dL

Body Mass Index (BMI) in kg/m^2: weight in kilograms, height in meters

时间窗: Change from Baseline BMI at 8 weeks

weight and height will be combined to report BMI in kg/m\^2

Low-density lipoprotein (LDL) cholesterol

时间窗: Change from Baseline LDL cholesterol at 8 weeks

Fasting blood LDL cholesterol in mg/dL

Waist circumference

时间窗: Change from Baseline Waist circumference at 8 weeks

Waist circumference in centimeters measured at the superior border of the iliac crest

Triglyceride-Rich lipoprotein (TRLP) size

时间窗: Change from Baseline TRLP size at 8 weeks

Fasting blood subclasses (Large, medium, small) of TRLP in nmol/L measured by Nuclear Magnetic Resonance

Low-density lipoprotein (LDL) size

时间窗: Change from Baseline LDL size at 8 weeks

Fasting blood subclasses (Large, medium, small) of LDL in nmol/L measured by Nuclear Magnetic Resonance

High-density lipoprotein (HDL) size

时间窗: Change from Baseline HDL size at 8 weeks

Fasting blood subclasses (Large, medium, small) of HDL in μmol/L measured by Nuclear Magnetic Resonance

High-density lipoprotein (HLDL) cholesterol

时间窗: Change from Baseline HDL cholesterol at 8 weeks

Fasting blood HLDL cholesterol in mg/dL

Glucose

时间窗: Change from Baseline Glucose at 8 weeks

Fasting blood glucose in mg/dL

Diastolic Blood Pressure

时间窗: Change from Baseline Diastolic Blood Pressure at 8 weeks

Diastolic blood pressure in mmHg will be used to present the results of this variable, as follow: e.g. 85 mmHg

Ghrelin

时间窗: Change from Baseline Ghrelin at 8 weeks

Ghrelin in pg/mL

Visual Analog Scale (VAS) to Measure Perceived Hunger and Satiety

时间窗: Change from Baseline VAS of Hunger and Satiety at 8 weeks

"Visual Analog Scale to measure perceived hunger and satiety" to complete in the morning, fasting, 5 days before entering the study and the last 5 days to end the study (8th week). The VAS consist of 8 questions followed each by a line of 10cm in which the person marks a position corresponding to his/her feelings about hunger and satiety. A higher score (10) means the person feels with more hunger or satisfied.

Dietary lutein+zeaxanthin levels

时间窗: Change from Baseline Dietary lutein+zeaxanthin levels at 8 weeks

Dietary lutein+zeaxanthin levels in micrograms

Apolipoprotein A1 (ApoA1)

时间窗: Change from Baseline ApoA1 at 8 weeks

Fasting blood ApoA1 in mg/L measured by Nuclear Magnetic Resonance

次要结局

  • Ancestry Informative Marker(Baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jacqueline Barona Acevedo

Principal Investigator

Universidad de Antioquia

研究点 (1)

Loading locations...

相似试验